Immunology

Items 271-280 of 293

per page
Set Descending Direction
  1. anti-Periostin, mAb (Stiny-1)
    AG-20B-0033
    AG-20B-0033-C100100 µg
    CHF 470.00
    Mouse Periostin is detected by immunoblotting using anti-Periostin, mAb (Stiny-1) (Prod. No AG-20B-0033).
Whole tissue extracts from mouse liver (lane 1) or mammary tumor (lane 2) were separated by SDS-PAGE under reducing conditions, transferred to
  2. anti-Periostin, mAb (Stiny-1) (Biotin)
    AG-20B-0033B
    AG-20B-0033B-C100100 µg
    CHF 500.00
  3. anti-Periostin, mAb (Stiny-1) (preservative free)
    AG-20B-0033PF
    AG-20B-0033PF-C100100 µg
    CHF 470.00
    anti-Periostin, mAb (Stiny-1) (preservative free)
  4. anti-Thymidine Glycol [TG], mAb (2E8)
    JAI-MTG-100P.
    JAI-MTG-100P100 µg
    CHF 598.00
  5. anti-TIGIT (human), mAb (ANCTG6/10A6) (Biotin)
    ANC-340-030.
    ANC-340-030100 µg
    CHF 423.00
  6. anti-TIGIT (human), mAb (ANCTG6/10A6) (R-PE)
    ANC-340-050.
    ANC-340-050120 tests
    CHF 455.00
    anti-TIGIT (human), mAb (ANCTG6/10A6) (R-PE)
  7. anti-TLR2, mAb (ABM3A87)
    AG-20T-0300
    AG-20T-0300-C100100 µg
    CHF 390.00
    Western blot analysis of TLR2 using anti-TLR2, mAb (ABM3A87) (AG-20T-0300) at 2µg/ml on mouse embryonic liver lysate.
  8. anti-TLR2, mAb (ABM3A87) (APC)
    AG-20T-0300C
    AG-20T-0300C-C100100 µg
    CHF 430.00
    Intracellular flow cytometry analysis of TLR2 in PBMCs (Monocytes) using 0.5µg/106 cells of anti-TLR2, mAb (ABM3A87) (APC) (AG-20T-0300C). Green represents the isotype control; red represents APC-conjugated anti-TLR2, mAb (ABM3A87) (APC).
  9. anti-TLR2, mAb (ABM3A87) (FITC)
    AG-20T-0300F
    AG-20T-0300F-C100100 µg
    CHF 410.00
    Intracellular flow cytometry analysis of TLR2 in A) PBMCs (Lymphocytes) and B) PBMCs (Monocytes) using 0.5µg/106 cells of anti-TLR2, mAb (ABM3A87) (FTIC) (AG-20T-0300F). Green represents the isotype control; red represents FTIC-conjugated anti-

Items 271-280 of 293

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.